Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Change in Cash: 2010-2024

Historic Change in Cash for China Pharma Holdings (CPHI) over the last 15 years, with Dec 2024 value amounting to -$796,959.

  • China Pharma Holdings' Change in Cash fell 1631.12% to -$357,407 in Q3 2025 from the same period last year, while for Sep 2025 it was -$451,066, marking a year-over-year increase of 30.73%. This contributed to the annual value of -$796,959 for FY2024, which is 31.48% down from last year.
  • As of FY2024, China Pharma Holdings' Change in Cash stood at -$796,959, which was down 31.48% from -$606,133 recorded in FY2023.
  • In the past 5 years, China Pharma Holdings' Change in Cash ranged from a high of $3.9 million in FY2021 and a low of -$2.8 million during FY2022.
  • Moreover, its 3-year median value for Change in Cash was -$796,959 (2024), whereas its average is -$1.4 million.
  • In the last 5 years, China Pharma Holdings' Change in Cash surged by 1,816.91% in 2021 and then tumbled by 172.51% in 2022.
  • Yearly analysis of 5 years shows China Pharma Holdings' Change in Cash stood at -$227,234 in 2020, then skyrocketed by 1,816.91% to $3.9 million in 2021, then tumbled by 172.51% to -$2.8 million in 2022, then soared by 78.57% to -$606,133 in 2023, then tumbled by 31.48% to -$796,959 in 2024.